|
FASTKD2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.700470E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.879000E-01 |
| Normal-vs-Stage2 |
6.953200E-01 |
| Normal-vs-Stage3 |
3.197900E-04 |
| Normal-vs-Stage4 |
4.15320000000108E-05 |
| Stage1-vs-Stage2 |
9.918200E-01 |
| Stage1-vs-Stage3 |
4.194200E-04 |
| Stage1-vs-Stage4 |
8.4579000000029E-05 |
| Stage2-vs-Stage3 |
4.198200E-02 |
| Stage2-vs-Stage4 |
1.284450E-02 |
| Stage3-vs-Stage4 |
4.533000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.391600E-02 |
| Normal-vs-AfricanAmerican |
1.554410E-02 |
| Normal-vs-Asian |
3.692400E-01 |
| Caucasian-vs-AfricanAmerican |
3.521000E-01 |
| Caucasian-vs-Asian |
9.506000E-01 |
| AfricanAmerican-vs-Asian |
7.732600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.180500E-04 |
| Normal-vs-Female |
8.942600E-01 |
| Male-vs-Female |
4.47190000000264E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.004010E-02 |
| Normal-vs-Age(41-60Yrs) |
5.176100E-02 |
| Normal-vs-Age(61-80Yrs) |
2.929800E-02 |
| Normal-vs-Age(81-100Yrs) |
4.073600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.408200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.380800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.818800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.407400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.861600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.165000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.606200E-01 |
| Normal-vs-Grade 2 |
8.662200E-01 |
| Normal-vs-Grade 3 |
4.677200E-03 |
| Normal-vs-Grade 4 |
1.30390000019354E-07 |
| Grade 1-vs-Grade 2 |
5.341200E-01 |
| Grade 1-vs-Grade 3 |
4.450200E-02 |
| Grade 1-vs-Grade 4 |
4.786800E-04 |
| Grade 2-vs-Grade 3 |
7.353600E-04 |
| Grade 2-vs-Grade 4 |
1.86109999633643E-08 |
| Grade 3-vs-Grade 4 |
2.522700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.120250E-01 |
| Normal-vs-ccB subtype |
2.21119999999075E-05 |
| ccA subtype-vs-ccB subtype |
1.06950004408191E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.504300E-02 |
| Normal-vs-N1 |
9.964100E-02 |
| N0-vs-N1 |
2.231800E-01 |
|
|
